Loading patent…
AssigneesAphea. Bio NV, Fundación Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Medina
InventorsFrederik ROELS, Isabel VERCAUTEREN, Jens MAINTZ, Steven VANDENABEELE, Emma LAGAE, Thomas SIMON
Estimating the term…
The current invention relates to a purified bacterial strain for conferring a broad-spectrum pathogen control or resistance to a plant, wherein said strain comprises at least one 16S nucleotide sequence, said 16S nucleotide sequence shows at least 95% sequence identity to SEQ ID No 2 over the entire length of said sequence and comprises a nucleotide signature sequence according to SEQ ID No 1. The invention also relates to a bacterial population and to a formulation for conferring a broad-spectrum pathogen control or resistance to a plant, as well as to the use of such purified bacterial strain, bacterial population or formulation to control a pathogen in a plant. In addition, the invention relates to a compound having the formula C21H23NO4. The invention also relates to a method for conferring a broad-spectrum pathogen control or resistance in a plant, and to the use of Takanawaene and/or C21H23NO4 compounds for controlling a pathogen in a plant.
A purified bacterial strain for conferring a broad-spectrum pathogen control or resistance to a plant, wherein said strain comprises at least one 16S nucleotide sequence, said 16S nucleotide sequence shows at least 95% sequence identity to SEQ ID No 2 over the entire length of said sequence and comprises a nucleotide signature sequence according to SEQ ID No 1.
A method for controlling a pathogen in a plant, comprising applying a Takanawaene and/or a compound having the formula C21H23NO4 to the plant.
A compound having the formula C21H23NO4.
(canceled)
Dependencies are inferred from the claim text.